These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 11063417

  • 1. Can kinetic analysis be a tool for evaluating pore characteristics?
    Bulgarelli E, Forni F, Bernabei MT.
    J Microencapsul; 2000; 17(6):701-10. PubMed ID: 11063417
    [Abstract] [Full Text] [Related]

  • 2. Effect of matrix composition and process conditions on casein-gelatin beads floating properties.
    Bulgarelli E, Forni F, Bernabei MT.
    Int J Pharm; 2000 Apr 05; 198(2):157-65. PubMed ID: 10767565
    [Abstract] [Full Text] [Related]

  • 3. Casein/gelatin beads: I. Cross-linker solution composition effect on cross-linking degree.
    Bulgarelli E, Forni F, Bernabei MT.
    Int J Pharm; 1999 Nov 15; 190(2):175-82. PubMed ID: 10547457
    [Abstract] [Full Text] [Related]

  • 4. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM, Takezoe K, Yamaura K.
    Biomed Mater Eng; 2004 Nov 15; 14(4):371-82. PubMed ID: 15472386
    [Abstract] [Full Text] [Related]

  • 5. Physicochemical characterization and enzymatic degradation of casein microcapsules prepared by aqueous coacervation.
    Santinho AJ, Ueta JM, Freitas O, Pereira NL.
    J Microencapsul; 2002 Nov 15; 19(5):549-58. PubMed ID: 12433299
    [Abstract] [Full Text] [Related]

  • 6. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
    Leucuţa SE.
    J Microencapsul; 1990 Nov 15; 7(2):209-17. PubMed ID: 2329447
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL, Hao WH.
    Drug Dev Ind Pharm; 1998 Jun 15; 24(6):557-62. PubMed ID: 9876623
    [Abstract] [Full Text] [Related]

  • 8. Preparation and pharmaceutical evaluation of new sustained-release capsule including starch-sponge matrix (SSM).
    Shibata N, Nishumura A, Naruhashi K, Nakao Y, Miura R.
    Biomed Pharmacother; 2010 May 15; 64(5):352-8. PubMed ID: 20006463
    [Abstract] [Full Text] [Related]

  • 9. Glutaraldehyde cross-linked bovine casein microspheres as a matrix for the controlled release of theophylline: in-vitro studies.
    Latha MS, Jayakrishnan A.
    J Pharm Pharmacol; 1994 Jan 15; 46(1):8-13. PubMed ID: 8201534
    [Abstract] [Full Text] [Related]

  • 10. Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents.
    Choi BY, Park HJ, Hwang SJ, Park JB.
    Int J Pharm; 2002 Jun 04; 239(1-2):81-91. PubMed ID: 12052693
    [Abstract] [Full Text] [Related]

  • 11. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
    Fu HX, Li H, Zhang FZ, Zhao YZ, Wan CW, Chen MT, Jia XC, Yan L, Sun CC, Xu YY.
    Drug Dev Ind Pharm; 2012 Jun 04; 38(6):670-8. PubMed ID: 22469006
    [Abstract] [Full Text] [Related]

  • 12. Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans.
    Narayani R, Rao KP.
    J Biomater Sci Polym Ed; 1995 Jun 04; 7(1):39-48. PubMed ID: 7662616
    [Abstract] [Full Text] [Related]

  • 13. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K, Winter G, Fricker G, Coester C.
    Eur J Pharm Biopharm; 2010 Sep 04; 76(1):1-9. PubMed ID: 20420904
    [Abstract] [Full Text] [Related]

  • 14. Tablet and capsule hydrophilic matrices based on heterodisperse polysaccharides having porosity-independent in vitro release profiles.
    Kelly ML, Tobyn MJ, Staniforth JN.
    Pharm Dev Technol; 2000 Sep 04; 5(1):59-66. PubMed ID: 10669919
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
    Pereira Camelo SR, Franceschi S, Perez E, Girod Fullana S, Ré MI.
    Drug Dev Ind Pharm; 2016 Sep 04; 42(6):985-97. PubMed ID: 26548427
    [Abstract] [Full Text] [Related]

  • 16. Casein-based formulations as promising controlled release drug delivery systems.
    Elzoghby AO, El-Fotoh WS, Elgindy NA.
    J Control Release; 2011 Aug 10; 153(3):206-16. PubMed ID: 21338636
    [Abstract] [Full Text] [Related]

  • 17. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles.
    Bussemer T, Bodmeier R.
    Int J Pharm; 2003 Nov 28; 267(1-2):59-68. PubMed ID: 14602384
    [Abstract] [Full Text] [Related]

  • 18. The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres.
    Vandelli MA, Forni F, Iannuccelli V, Cameroni R.
    J Pharm Belg; 1991 Nov 28; 46(6):381-8. PubMed ID: 1783972
    [Abstract] [Full Text] [Related]

  • 19. Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration.
    Kimura S, Imai T, Otagiri M.
    Pharm Acta Helv; 1991 Nov 28; 66(4):120-4. PubMed ID: 1758897
    [Abstract] [Full Text] [Related]

  • 20. Development and characterization of gelatin and ethylcellulose microparticles designed as platforms to delivery fluoride.
    de Francisco LM, Cerquetani JA, Bruschi ML.
    Drug Dev Ind Pharm; 2013 Nov 28; 39(11):1644-50. PubMed ID: 23034061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.